New research from Washington State University in collaboration with five other institutions suggests that automated insulin ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Dexcom was issued with an FDA warning letter after issues with “manufacturing processes and quality management systems.” ...

New research from Washington State University in collaboration with five other institutions suggests that automated insulin ...

Tandem Diabetes Care, Inc.’s TNDM fourth-quarter 2024 performance was driven by its impressive range of new products. The company’s impressive strategic initiatives provide a favorable opportunity for ...

We recently published a list of 10 Best Growth Stocks Under $100 to Buy Now. In this article, we are going to take a look at ...

DexCom said that on Tuesday it received a warning letter from the U.S. FDA following inspections at its facilities in San Diego, Calif., and Mesa, Ariz. related to concerns about manufacturing ...

A recently published study highlighted the strong performance of the Insulet (Nasdaq:PODD) Omnipod 5 in children and young ...

The next-generation Control-IQ+ algorithm, used to enable automated insulin ... t:slim pump with Control-IQ+ technology to multiple daily injection regimens, with both groups using the Dexcom ...

They can pause or take the pump off for intermittent breaks, too. ViCentra designed 10 bright color options as well, giving customers a more personal choice. ViCentra launched its hybrid closed-loop ...

Both groups used a Dexcom G6 Continuous Glucose Monitoring (CGM ... The Company’s pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ ...